Publications

Interim Australian Technical Advisory Group on Immunisation (ATAGI) advice on the administration of RSV - Specific monoclonal antibodies to Aboriginal and Torres Strait Islander infants and children

Australian Technical Advisory Group on Immunisation (ATAGI) advice on counterfeit rabies vaccines and rabies immunoglobulin: Guidance for travellers and healthcare providers

Read the independent evaluation of the Council of Australian Governments (COAG) s19(2) Exemptions Initiative.

The Hearing Services Program webinar, published on 29 October 2026, provided an update on current Hearing Services Program activities, upcoming initiatives and key compliance matters. Read responses to questions relating to the topics covered during the webinar.

This postcard contains information about volunteering opportunities in aged care and links to resources for Volunteer Managers and providers.

This document summarises stakeholder feedback on the draft Medical Research Future Fund (MRFF) Strategy for 2026-2031 and Priorities for 2026-2028.

This document sets out priority areas for investment under the Medical Research Future Fund from 2026 to 2028. It supports the Australian Medical Research and Innovation Strategy 2026-2031 by guiding investment towards areas of greatest need and opportunity.

This document sets the direction for the Medical Research Future Fund from 2026 to 2031. It outlines the vision, aim and strategic objectives for investment, and the guiding principles that support funding decisions and implementation.

Our inclusion framework shows our commitment to a diverse and inclusive workforce that reflects the community we serve. By valuing different identities and views, we strengthen our organisation. We also create a workplace that is culturally safe, accessible, inclusive and respectful.

Provides guidance to Support at Home providers on arrangements for the End-of-Life Pathway Extension, effective from 8 March 2027, and how to prepare and implement the changes.

These guides provide information about the mandatory care minutes and 24/7 registered nurse requirements. Learn more about each requirement, including delivery of care minutes, registered nurse coverage and reporting obligations.

This certification statement, signed by Director-General of the Australian Centre for Disease Control, Professor Zoe Wainer on 20 October 2026, certifies that Phase 3 of the Sexually Transmissible Infections campaign complies with relevant guidelines and policies.

Communiqué summarising key discussions, insights and outcomes from the Technical Advisory Group on NDIS Functional Capacity meeting held on 2 November 2026.

This document contains the member biographies of the Medicare Benefits Schedule (MBS) Review Advisory Committee (MRAC).

This poster aims to prevent syphilis during pregnancy by encouraging First Nations communities to stay on top of their sexual health by using protection and booking an STI test today.

This document provides a list of biosimilar medicines that are subsidised under the Pharmaceutical Benefits Scheme (PBS).

This fact sheet provides information about a biosimilar brand of tocilizumab listed on the Pharmaceutical Benefits Scheme (PBS).

This poster illustrates how common STIs are in Australia and encourages First Nations communities to stay on top of their sexual health by using protection and booking an STI test today.

This poster communicates how regular testing is part of looking after each other. It encourages First Nations communities to stay on top of their sexual health by using protection and booking an STI test today.

Beforeplay campaign poster that encourages Australians to stay on top of their sexual health by using protection and booking an STI test today.

Beforeplay campaign poster that encourages Australians to stay on top of their sexual health by using protection and booking an STI test today.

Beforeplay campaign poster that encourages Australians to stay on top of their sexual health by using protection and booking an STI test today.

This publication reflects on the first two years of the Aged Care On-site Pharmacist Measure, including changes to the Measure and participation and uptake from 1 July 2024 to 30 June 2026.

This publication summarises stakeholder feedback on the proposed funding model, pharmacist role, training requirements, health outcome indicators, reporting and transition arrangements for the Aged Care On-site Pharmacist Measure.

This manual is for aged care service providers who receive funding under the National Aboriginal and Torres Strait Islander Flexible Aged Care Program. It outlines the requirements of the program including service planning, staffing, health and safety, quality and advocacy.